Beta-Blocker Reduces Lung Inflammation in Critical COVID-19 Beta-Blocker Reduces Lung Inflammation in Critical COVID-19

In a pilot trial, intravenous metoprolol given to patients with acute respiratory distress syndrome brought on by COVID-19 was safe, reduced lung inflammation, and improved oxygenation.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news